Precision Biosciences Inc financial data

Symbol
DTIL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
302 East Pettigrew Street, Suite A 100, Durham, NC
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 430 % +38.8%
Debt-to-equity 239 % -37.4%
Return On Equity 17.6 %
Return On Assets 5.2 %
Operating Margin -21.6 % +42.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.67M shares -93.6%
Common Stock, Shares, Outstanding 7.48M shares -93.5%
Entity Public Float 59.1M USD -65.3%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 7.29M shares +89.8%
Weighted Average Number of Shares Outstanding, Diluted 7.29M shares +89.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 75.1M USD +43.6%
Research and Development Expense 57M USD +81.4%
General and Administrative Expense 34.3M USD -15.3%
Operating Income (Loss) -16.2M USD +17.3%
Net Income (Loss) Attributable to Parent 8.62M USD -103%
Earnings Per Share, Basic 0.17 USD/shares -7.14%
Earnings Per Share, Diluted 0.14 USD/shares -7.14%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 98.8M USD -19.2%
Marketable Securities, Current 2.45M USD
Accounts Receivable, after Allowance for Credit Loss, Current 188K USD -94.6%
Other Assets, Current 471K USD +35%
Assets, Current 111M USD -24.2%
Deferred Income Tax Assets, Net 3.28M USD +181%
Property, Plant and Equipment, Net 3.56M USD -59.2%
Operating Lease, Right-of-Use Asset 7.39M USD +587%
Intangible Assets, Net (Excluding Goodwill) 388K USD -60.3%
Other Assets, Noncurrent 224K USD -4.27%
Assets 153M USD -6.75%
Accounts Payable, Current 958K USD +80.4%
Employee-related Liabilities, Current 3.59M USD -6.17%
Contract with Customer, Liability, Current 175K USD -99%
Liabilities, Current 12M USD -76.3%
Contract with Customer, Liability, Noncurrent 26.6M USD -64%
Deferred Income Tax Liabilities, Net 3.28M USD +181%
Operating Lease, Liability, Noncurrent 6.75M USD
Other Liabilities, Noncurrent 188K USD -75.5%
Liabilities 88.4M USD -34.7%
Retained Earnings (Accumulated Deficit) -465M USD +1.82%
Stockholders' Equity Attributable to Parent 64.9M USD +123%
Liabilities and Equity 153M USD -6.75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19M USD +39.7%
Net Cash Provided by (Used in) Financing Activities 40.1M USD +5311%
Net Cash Provided by (Used in) Investing Activities -26K USD +96.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 7.51M shares -93.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 121M USD -0.74%
Interest Paid, Excluding Capitalized Interest, Operating Activities 526K USD +13.4%
Deferred Tax Assets, Valuation Allowance 139M USD +14.6%
Operating Lease, Liability 8.03M USD +437%
Lessee, Operating Lease, Liability, to be Paid 9.95M USD +547%
Property, Plant and Equipment, Gross 31.8M USD -5.52%
Operating Lease, Liability, Current 1.28M USD -14.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.02M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.96M USD +81.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +12.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.92M USD +4173%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.08M USD
Deferred Tax Assets, Operating Loss Carryforwards 45.5M USD +24.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.14M USD
Operating Lease, Payments 462K USD -19.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 12M USD -23.1%
Interest Expense 1.97M USD -7.86%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%